摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(叔丁氧基羰基)-苯硼酸 | 220210-56-0

中文名称
3-(叔丁氧基羰基)-苯硼酸
中文别名
3-叔丁氧羰基苯硼酸;3-BOC-苯硼酸;3-叔丁酯基苯硼酸;3-叔丁氧基羰基苯基硼酸;3-(叔丁氧羰基)苯硼酸;3-(叔丁氧基羰基)苯硼酸
英文名称
3-(tert-butoxycarbonyl)phenylboronic acid
英文别名
{3-[(tert-butoxy)carbonyl]phenyl}boronic acid;(3-(tert-butoxycarbonyl)phenyl)-boronic acid;(3-(tert-butoxycarbonyl)phenyl)boronic acid;[3-(tert-butoxycarbonyl)phenyl]boronic acid;3-(tert-butoxycarbonyl)phenyl boronic acid;3-(tert-butoxycarbonylphenyl)boronic acid;[3-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]boronic acid
3-(叔丁氧基羰基)-苯硼酸化学式
CAS
220210-56-0
化学式
C11H15BO4
mdl
MFCD01630855
分子量
222.049
InChiKey
HVJDVHCPCSZDSR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    96-102°C
  • 沸点:
    375.0±44.0 °C(Predicted)
  • 密度:
    1.15±0.1 g/cm3(Predicted)
  • 溶解度:
    溶于甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    2.62
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    66.8
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2931900090
  • 安全说明:
    S26,S36/37/39
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335
  • 储存条件:
    请保持冷敷。

SDS

SDS:223006a7fc36e99836316c1170c71b16
查看
Material Safety Data Sheet

Section 1. Identification of the substance
3-t-Butoxycarbonylphenylboronic acid
Product Name:
Synonyms: t-Butyl 3-boronobenzoate

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
3-t-Butoxycarbonylphenylboronic acid
Ingredient name:
CAS number: 220210-56-0

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C11H15BO4
Molecular weight: 222.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

3-(叔丁氧基羰基)-苯硼酸可用作有机合成中间体和医药中间体,主要应用于实验室研发过程和化工生产过程中。

采用10L玻璃反应器并配备机械搅拌、温度计及恒压滴液漏斗,在氮气保护下加入3摩尔间羧基苯硼酸与4kg四氢呋喃,回流条件下以恒速滴加4.5摩尔氯化亚砜,持续反应4小时。随后降温至0-5℃,分批添加7.5摩尔叔丁醇钾并继续搅拌反应1小时。加入2kg后用醋酸酸化,静置、分液。收集有机相进行浓缩以获得粗品,再加入2kg石油醚进行重结晶,最终得到纯度为98%、收率为95%的固体产物3-(叔丁氧基羰基)-苯硼酸

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(叔丁氧基羰基)-苯硼酸三苯基膦双(三氟甲磺酰亚胺)金 作用下, 以 甲苯 为溶剂, 反应 1.0h, 以96%的产率得到苯甲酸
    参考文献:
    名称:
    Gold-Catalyzed Proto- and Deuterodeboronation
    摘要:
    A mild gold-catalyzed protodeboronation reaction, which does not require acid or base additives and can be carried out in "green" solvents, is described. As a result, the reaction is very functional-group-tolerant, even to acid- and base-sensitive functional groups, and should allow for the boronic acid group to be used as an effective traceless directing or blocking group. The reaction has also been extended to deuterodeboronations for regiospecific ipso-deuterations of aryls and heteroaryls from the corresponding organoboronic acid. Based on density functional theory calculations, a mechanism is proposed that involves nucleophilic attack of water at boron followed by rate-limiting B-C bond cleavage and facile protonolysis of a Au-sigma-phenyl intermediate.
    DOI:
    10.1021/acs.joc.5b01041
点击查看最新优质反应信息

文献信息

  • Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
    申请人:Vertex Pharmaceuticals Incorporated
    公开号:US20150231142A1
    公开(公告)日:2015-08-20
    The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
    本发明涉及含有上皮通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物(A式、B式、C式或D式)的药物组合物。该发明还涉及这些药物配方,以及使用这些组合物治疗CFTR介导的疾病,特别是囊性纤维化的方法。
  • Shuttle arylation by Rh(I) catalyzed reversible carbon–carbon bond activation of unstrained alcohols
    作者:Marius D.R. Lutz、Valentina C.M. Gasser、Bill Morandi
    DOI:10.1016/j.chempr.2021.02.029
    日期:2021.4
    transfer hydrogenation and borrowing hydrogen reactions paved the way to manipulate simple alcohols in previously unthinkable manners and circumvented the need for hydrogen gas. Analogously, transfer hydrocarbylation could greatly increase the versatility of tertiary alcohols. However, this reaction remains unexplored because of the challenges associated with the catalytic cleavage of unactivated C–C bonds
    转移氢化和借用氢反应的出现为以以前无法想象的方式操作简单的醇铺平了道路,并避免了对氢气的需求。类似地,转移烃基化可以大大提高叔醇的多功能性。然而,由于与未活化的CC键的催化裂解有关的挑战,该反应仍未得到探索。在本文中,我们报道了(I)催化的穿梭芳基化反应,通过氧化还原中性β-碳消除机制,在未应变的三芳基醇中裂解C(sp 2)-C(sp 3)键。使用良性醇作为潜在的C,实现了从叔醇到酮的取代(杂)芳基的选择性转移烃基化-亲核试剂。所有初步的机械实验都支持可逆的β-碳消除/迁移插入机制。在更广泛的背景下,这种新颖的反应性为催化叔醇的操作提供了新的平台。
  • Pyrrolo-pyridine kinase modulators
    申请人:Arnold D. William
    公开号:US20060030583A1
    公开(公告)日:2006-02-09
    The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    本发明提供了新型吡咯-吡啶激酶调节剂以及利用这些新型吡咯-吡啶激酶调节剂治疗由激酶活性介导的疾病的方法。
  • A new approach to silicon rhodamines by Suzuki–Miyaura coupling – scope and limitations
    作者:Thines Kanagasundaram、Antje Timmermann、Carsten S Kramer、Klaus Kopka
    DOI:10.3762/bjoc.15.250
    日期:——

    Background: Silicon rhodamines are of particular interest because of their advantageous dye properties (fluorescence- and biostability, quantum efficiency, tolerance to photobleaching). Therefore, silicon rhodamines find frequent application in STED (stimulated emission depletion) microscopy, as sensor molecules for, e.g., ions and as fluorophores for the optical imaging of tumors. Different strategies were already employed for their synthesis. Because of just three known literature examples in which Suzuki–Miyaura cross couplings gave access to silicon rhodamines in poor to moderate yields, we wanted to improve these first valuable experimental results.

    Results: The preparation of the xanthene triflate was enhanced and several boron sources were screened to find the optimal coupling partner. After optimization of the palladium catalyst, different substituted boroxines were assessed to explore the scope of the Pd-catalyzed cross-coupling reaction.

    Conclusions: A number of silicon rhodamines were synthesized under the optimized conditions in up to 91% yield without the necessity of HPLC purification. Moreover, silicon rhodamines functionalized with free acid moieties are directly accessible in contrast to previously described methods.

    背景:罗丹明因其有利的染料特性(荧光和生物稳定性、量子效率、对光漂白的耐受性)而特别受到关注。因此,罗丹明常用于STED(受激发射耗尽)显微镜,作为例如离子和肿瘤光学成像的荧光团的传感器分子。已经采用了不同的策略来合成它们。因为在仅有的三个已知文献实例中,铃木-宫浦交叉偶联以较差到中等产率得到了罗丹明,我们想要改进这些初步有价值的实验结果。 结果:提高了xanthene triflate的制备,并筛选了多种源以找到最佳的偶联伴侣。在优化了催化剂之后,评估了不同的取代氧烷来探索催化的交叉偶联反应的范围。 结论:在优化的条件下合成了多种罗丹明,产率高达91%,无需HPLC纯化。此外,与先前描述的方法相比,带有自由酸基团的功能化罗丹明可以直接获得。
  • Synthesis and evaluation of novel thiazole-based derivatives as selective inhibitors of DNA-binding domain of the androgen receptor
    作者:Ruixue Xu、Ye Tian、Shenzhen Huang、Jiang Yu、Yufang Deng、Miao Zhan、Tao Zhang、Fangying Wang、Lifeng Zhao、Yuanwei Chen
    DOI:10.1111/cbdd.13068
    日期:2018.1
    A series of thiazole-based inhibitors selectively targeting DNA-binding domain of the androgen receptor (AR) were synthesized and evaluated, and the SAR data were summarized. We identified a novel compound SKLB-C2807 that effectively inhibited the human prostate cancer cell line LNCaP/AR with the IC50 value of 0.38 μm without significant antiproliferative effects on other cell lines PC-3 (AR-negative)
    合成和评估了一系列选择性靶向雄激素受体(AR)DNA结合域的噻唑抑制剂,并总结了SAR数据。我们鉴定了新的化合物SKLB-C2807,有效地抑制人前列腺癌细胞系LNCaP / AR与IC 50的0.38μ值米而对其它细胞系PC-3(AR-负),SW620,MCF-显著抗增殖作用7(ER阳性)和L-O2(非癌性)。该化合物还大大降低了前列腺特异性抗原的表达。研究了其与AR-DBD的结合方式。这些努力为开发下一代抗雄激素奠定了基础。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫